Form 4 for LUNG Pulmonx Corp
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001209191-23-016000 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-03 | 2023-03-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | A - Grant | $0.00 | +173.5K | 1.21M | +17% | $0 |
| DM | 2023-03-03 | 2023-03-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $11.03 | -2,895 | 1.03M | -0.3% | -$31.9K |
| D | 2023-03-03 | 2023-03-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | A - Grant | $0.00 | +356.3K | 356.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | A | A | 173,500 | $0.00 | 1,206,080 | D | — | — | (F4) Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2023. |
| 2 | Common | Common Stock | 2023-03-01 | S | D | 1,184 | $11.03 | 1,034,291 | D | — | — | (F2) Includes 1,162 shares acquired by the reporting person under the Issuer's 2020 Employee Stock Purchase Plan on February 15, 2023. |
| 3 | Common | Common Stock | 2023-03-01 | S | D | 1,711 | $11.03 | 1,032,580 | D | — | — | |
| 4 | Derivative | Employee Stock Option (right to buy) | 2023-03-01 | A | A | 356,300 | $0.00 | 356,300 | D | $11.48 · — to 2033-02-28 | 356,300 Common Stock | (F5) The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2023. |